BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38895635)

  • 1. Crebanine, an aporphine alkaloid, induces cancer cell apoptosis through PI3K-Akt pathway in glioblastoma multiforme.
    Yeh PS; Liu CT; Yu CY; Chang YC; Lin SY; Li YC; Luan YZ; Sung WW
    Front Pharmacol; 2024; 15():1419044. PubMed ID: 38895635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway.
    Zheng X; Li W; Xu H; Liu J; Ren L; Yang Y; Li S; Wang J; Ji T; Du G
    Acta Pharm Sin B; 2021 Nov; 11(11):3465-3480. PubMed ID: 34900530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voxtalisib and low intensity pulsed ultrasound combinatorial effect on glioblastoma multiforme cancer stem cells via PI3K/AKT/mTOR.
    Tutak I; Ozdil B; Uysal A
    Pathol Res Pract; 2022 Nov; 239():154145. PubMed ID: 36240647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin induces MGMT
    Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q
    Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma.
    Li Q; Liu X; Mao J; Liu S; Hou B; Li K; Fang D
    Biochem Biophys Res Commun; 2023 Oct; 676():149-157. PubMed ID: 37517217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway.
    Tang Q; Cao H; Tong N; Liu Y; Wang W; Zou Y; Xu L; Zeng Z; Xu W; Yin Z; Ma W; Wang Q
    Phytomedicine; 2022 May; 99():154016. PubMed ID: 35278900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway.
    Zheng L; Yang S; Xu R; Yang Y; Quan J; Lin Z; Quan C
    Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
    Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
    J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crebanine induces ROS-dependent apoptosis in human hepatocellular carcinoma cells
    Tan J; Xiang Y; Xiong Y; Zhang Y; Qiao B; Zhang H
    Front Pharmacol; 2023; 14():1069093. PubMed ID: 36874025
    [No Abstract]   [Full Text] [Related]  

  • 10. Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma.
    Guo T; Wu C; Zhang J; Yu J; Li G; Jiang H; Zhang X; Yu R; Liu X
    Cell Commun Signal; 2023 Dec; 21(1):363. PubMed ID: 38115126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concentration of γ‑H2AX correlates with a marker of apoptotic suppression and PI3K/Akt pathway upregulation in glioblastoma multiforme.
    Banjarnahor CTU; Hardiany NS; Wahjoepramono EJ; Hariyanto AD; Sadikin M
    Oncol Lett; 2023 Apr; 25(4):149. PubMed ID: 36936016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y; Xie P
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development.
    Zhao HF; Wang J; Shao W; Wu CP; Chen ZP; To ST; Li WP
    Mol Cancer; 2017 Jun; 16(1):100. PubMed ID: 28592260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
    Harder BG; Peng S; Sereduk CP; Sodoma AM; Kitange GJ; Loftus JC; Sarkaria JN; Tran NL
    Mol Med; 2019 Nov; 25(1):49. PubMed ID: 31726966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor 1/insulin-like growth factor 1 receptor signaling protects against cell apoptosis through the PI3K/AKT pathway in glioblastoma cells.
    Zhang M; Liu J; Li M; Zhang S; Lu Y; Liang Y; Zhao K; Li Y
    Exp Ther Med; 2018 Aug; 16(2):1477-1482. PubMed ID: 30116397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
    Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
    Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
    Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma.
    Cai J; Ye Z; Hu Y; Ye L; Gao L; Wang Y; Sun Q; Tong S; Zhang S; Wu L; Yang J; Chen Q
    Cell Death Dis; 2023 Mar; 14(3):211. PubMed ID: 36966152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway.
    Zhang W; Dong J; Xu J; Qian Y; Chen D; Fan Z; Yang H; Xiang J; Xue X; Luo X; Jiang Y; Wang Y; Huang Z
    Biochem Pharmacol; 2024 May; 223():116112. PubMed ID: 38458331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
    Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
    Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.